Prospective evaluation of two dosing equations for theophylline in premature infants

Pharmacotherapy

Volumn 16, Issue 5 I, 1996, Pages 769-776

  Bhatt Mehta, Varsha ^a,b   Donn, Steven M ^a   Schork, M Anthony ^a   Reed, Susan ^a   Johnson, Cary E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; THEOPHYLLINE DERIVATIVE;

APNEA; ARTICLE; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PREMATURITY; THEOPHYLLINE BLOOD LEVEL;

APNEA; BRONCHODILATOR AGENTS; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MODELS, BIOLOGICAL; PROSPECTIVE STUDIES; THEOPHYLLINE;

EID: 0029762932     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Shannon DC, Gotay F, Stein IM, Rogers MC, Todres ID, Moylan FMB. Prevention of apnea and bradycardia in low birth weight infants. Pediatrics 1975;55:589-94.
2. Alden ER, Mandelkorn T, Woodrum DE, Wennberg RP, Parks CR, Hodson WA. Morbidity and mortality of infants weighing less than 1000 grams in an intensive care nursery. Pediatrics 1972;50:40-9.
3. Daily WJR, Klaus M. Apnea in premature infants: monitoring, incidence, heart rate changes, and effect of environmental temperature. Pediatrics 1969;43:510-18.
4. Henderson-Smart DJ, Pettigrew AG, Campbell DJ. Clinical apnea and brainstem neural function in preterm infants. N Engl J Med 1983;308:353-7.
5. Martin RJ, Miller MJ, Carlo WA. Pathogenesis of apnea in preterm infants. J Pediatr 1986;109:733-41.
6. Gerhardt T, McCarthy J, Bancalari E. Effect of aminophylline on respiratory center and reflex activity in premature infants with apnea. Pediatr Res 1983;17:199-201.
7. Uauy R, Shapiro DL, Smith B, Warshaw JB. Treatment of severe apnea in prematures with orally administered theophylline. Pediatrics 1975;55:595-8.
8. Davi MJ, Sankaran K, Simons KJ, et al. Physiologic changes induced by theophylline in the treatment of apnea in preterm infants. J Pediatr 1978;92:91-5.
9. Peabody J, Neese AL, Lucey JF, et al. Decreased hypoxic, hyperoxic and bradycardic episodes as responses of neonates to theophylline. Pediatr Res 1977;11:419.
10. Aranda JV, Sitar DS, Parsons WD, et al. Pharmacokinetic aspects of theophylline in premature newborns. N Engl J Med 1976;295:413-16.
11. Giacoia G, Jusko WJ, Menke J, et al. Theophylline pharmacokinetics in premature infants with apnea. J Pediatr 1976;89:829-32.
12. Cummiskey JM, Popa V. State-of-the-art: pharmacologic-therapeutic update, theophyllines: a review. J Asthma 1984;21:243-57.
13. Stile IL, Zolfaghari S, Hiatt IM, et al. Pharmacokinetics of theophylline in premature infants on the first day of life. Clin Ther 1986;8:336-41.
14. Takieddine FN, Tserng K, King KC, et al. Postnatal development of theophylline metabolism in preterm infants. Semin Perinatol 1981;5:351-8.
15. Estelle F, Simons R, Rigatto H, et al. Pharmacokinetics of theophylline in neonates. Semin Perinatol 1981;5:337-45.
16. Kraus DM, Fischer JH, Reitz SJ, et al. Alterations in theophylline metabolism during the first year of life. Clin Pharmacol Ther 1993;54:351-9.
17. Gal P, Boer H, Toback J, et al. Effect of asphyxia on theophylline clearance in newborns. South Med J 1982;75:836-8.
18. Moore ES, Faix RG, Banagale RC, et al. The population pharmacokinetics of theophylline in neonates and young infants. J Pharmacokinet Biopharm 1989;17:47-66.
19. Jones RAK, Baillie E. Dosage schedule for iv aminophylline in apnoea of prematurity, based on pharmacokinetic studies. Arch Dis Child 1979;54:190-3.
20. Bhatt-Mehta V, Johnson CE, Donn SM, Theisen V. Accuracy and reliability of dosing equations to individualize theophylline treatment in apnea of prematurity. Pharmacotherapy 1995;15: 246-50.
21. Nassif EG, Weinberger MN, Shannon D, et al. Theophylline disposition in infancy. J Pediatr 1981;98:158-60.
22. Anonymous. Theophylline. In: Rowe PC, e;d. Johns Hopkins, the Harriet Lane handbook, 12th ed. Chicago: Year Book, 1991:237.
23. Viscardi RM, Faix RG, Nicks JJ, Grasela TH. Efficacy of theophylline for prevention of post-extubation respiratory failure in very low birth weight infants. J Pediatr 1985;107:469-72.
24. Hendeles L, Weinberger M, Johnson G. Theophylline. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetics. San Francisco: Applied Therapeutics, 1980:95-138.
25. Donn SM, Roloff DW, Goldstein GW. Prevention of intraventricular hemorrhage in preterm infants by phenobarbitone. Lancet 1981;2:215-17.
26. Anonymous. Use of theophylline in infants. FDA Drug Bull 1985;15:16-17.
27. Lonnerholm G, Lindstrom B, Paalow L, Sedin G. Serum theophylline and caffeine clearance during first year of life. Eur J Clin Pharmacol 1983;24:371-80.
28. Gilman JT, Gal P, Levine RS, Hersh CB, Erkan NV. Factors influencing theophylline disposition in 179 newborn infants. Ther Drug Monit 1986;8:4-10.
29. Bada HS, Khanna NN, Somani SM, Tin TT. Interconversion of theophylline and caffeine in newborn infants. J Pediatr 1979;94:993-5.
30. Gilman JT, Gal P. Inadequacy of FDA guidelines for theophylline use in neonates. Drug Intell Clin Pharm 1986;20:481-4.
31. Murphy JE, Erkan NV, Fakhreddine F. New FDA guidelines for theophylline dosing in infants [letter]. Clin Pharm 1986;5:16.
32. Hogue SL, Phelps SJ. Evaluation of three dosing equations in infants less than or equal to one year of age. Clin Res 1990;38:982A.
33. Landay RA, Gonzalez MA, Taylor JC. Effect of phenobarbital on theophylline disposition. J Allergy Clin Immunol 1978;62:27-9.
34. Yeung CY, Tam LS, Chan A, Lee KH. Phenobarbitone prophylaxis for neonatal hyperbilirubinemia. Pediatrics 1971;48:372-6.
35. Valdes OS, Maurer HM, Shumway CN, Draper DA, Hossaini AA. Controlled clinical trial of phenobarbital and/or light in reducing neonatal hyperbilirubinemia in a predominantly negro population. J Pediatr 1971;79:1015-17.
36. Aranda JV, Grondin D, Sasynick BI. Pharmacologic considerations in the therapy of neonatal apnea. Pediatr Clin North Am 1981;28:113-33.
37. Grasela TH, Donn SM. Neonatal population pharmacokinetics of phenobarbital derived from routine clinical data. Dev Pharmacol Ther 1985;8:374-83.
38. Tserg K, Takieddine FN, King KC. Developmental aspects of theophylline metabolism in premature infants. Clin Pharmacol Ther 1983;33:522-8.